Prognostic value of CtIP/RBBP8 expression in breast cancer. - Wikidata - wikimedia - TriplyDB

Prognostic value of CtIP/RBBP8 expression in breast cancer.

Prognostic value of CtIP/RBBP8 expression in breast cancer.

http://www.wikidata.org/entity/Q37481139

about

Integrating Multi-omics Data to Dissect Mechanisms of DNA repair Dysregulation in Breast Cancer A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection.CtIP/Ctp1/Sae2, molecular form fit for function.The transcription factor GATA3 is required for homologous recombination repair by regulating CtIP expression.Neddylation inhibits CtIP-mediated resection and regulates DNA double strand break repair pathway choice.Deletion of 18q is a strong and independent prognostic feature in prostate cancer Speed matters: How subtle changes in DNA end resection rate affect repair.Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer.

P2860

Q31132980-62FAC8C4-E0B8-4F34-97CA-06E1E420B714 Q36098301-6DA61F8F-9104-484C-B93D-DFF26EFEA1CC Q38721827-3AB294AD-544D-4F0B-A54E-2F312F34987B Q38798176-3A5EC00C-BB6F-46AE-827E-47612E141EB2 Q38922310-312B85BB-EAD1-4917-8506-3CF0C18629B6 Q42316509-E30A0071-1F8A-4494-B1B3-9F740BEE933A Q42729571-CADEDB56-AF16-4896-BE16-F44E92EA53FF Q50106233-C71EC3C6-ABFD-4414-85A7-7AB440BEDAC6

P2860

Prognostic value of CtIP/RBBP8 expression in breast cancer.

http://www.wikidata.org/entity/Q37481139

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prognostic value of CtIP/RBBP8 expression in breast cancer.

@en

Prognostic value of CtIP/RBBP8 expression in breast cancer.

@nl

type

label

Prognostic value of CtIP/RBBP8 expression in breast cancer.

@en

Prognostic value of CtIP/RBBP8 expression in breast cancer.

@nl

prefLabel

Prognostic value of CtIP/RBBP8 expression in breast cancer.

@en

Prognostic value of CtIP/RBBP8 expression in breast cancer.

@nl

P1433

Q37481139-AC17D355-FB72-4386-B11C-0C057E83A6C2

P1476

Q37481139-B3BEB9EB-9D20-437C-8BB4-6EAB03085296

P2093

Q37481139-B88D928E-290F-422A-A708-D673CA512389

Q37481139-E1BF915A-2369-46BA-8839-CAA56E896FE0

P2860

Q37481139-025C3714-5F01-4B32-860B-2821077CA70B

Q37481139-09243212-4476-46D3-9BED-1F02A1596A8C

Q37481139-0D0ADB81-7D03-4265-AC9A-FA6488B8E5A6

Q37481139-0DA6886B-7224-472B-9AE8-257604F9F672

Q37481139-1192C143-56A1-47B2-886B-C367811359E7

Q37481139-147D21A2-9519-43C2-B1A2-067519DCC24E

Q37481139-149C1F00-FF5D-4E4A-88CD-7E103098B510

Q37481139-297E2F92-7982-4C77-A3DF-B2314C62BB59

Q37481139-40C54B0E-8252-49D8-AD00-FD9D37758149

Q37481139-4789045F-0AF0-4088-9166-A0198953374F

P304

Q37481139-229E5084-1F32-47F5-90D8-BC531D1494ED

P31

Q37481139-60E65C33-7128-453D-996E-6AE3E6326076

P356

Q37481139-86AF668E-D65F-46DB-94DC-92465D177D06

P407

Q37481139-E8C39FD2-CBAE-4602-906C-E84E396E336B

P433

Q37481139-76E7E4E8-9248-4D92-AD29-D982A2DC43F0

P478

Q37481139-AC00E32A-C146-4E72-8644-6BAF1A1E564A

P50

Q37481139-51A90087-BD31-4B7C-B945-CEFB74DDA682

Q37481139-77B96C8B-C277-484F-A860-2D69F4EF6E0E

Q37481139-F453F8F1-CF30-460E-8A2A-41E204AA6196

P577

Q37481139-AFAA6BBF-CA3C-4B1E-B0C4-5C10AB11E0D6

P5875

Q37481139-0405D993-5494-4C7A-A1BD-C7A7BFE7BBCD

P698

Q37481139-4580CEA2-A147-4C65-9171-B9B5D2D3BD3E

P932

Q37481139-5C0B96F3-2ED3-4262-942E-D5273C5BF92C

P356

P1433

Cancer Medicine

P1476

Prognostic value of CtIP/RBBP8 expression in breast cancer.

@en

P2093

Isabel Soria-Bretones

http://www.w3.org/2001/XMLSchema#string

Manuel Ruíz-Borrego

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of a carboxy-terminal BRCA1 interacting protein

Hallmarks of Cancer: The Next Generation

Nuclear localization and cell cycle-specific expression of CtIP, a protein that associates with the BRCA1 tumor suppressor

The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity

DNA damage-induced cell cycle checkpoint control requires CtIP, a phosphorylation-dependent binding partner of BRCA1 C-terminal domains

The DNA-damage response in human biology and disease

Human CtIP promotes DNA end resection

Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach

A gene-expression signature as a predictor of survival in breast cancer

Repeated observation of breast tumor subtypes in independent gene expression data sets

P304

774-783

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.141

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Miguel A Japón

P577

2013-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259631153

http://www.w3.org/2001/XMLSchema#string

P698

24403251

http://www.w3.org/2001/XMLSchema#string

P932

3892382

http://www.w3.org/2001/XMLSchema#string